Vanguard Investments Canada Announces Estimated 2023 Annual Capital Gains Distributions for the Vanguard ETFs®

Written by Customer Service on December 20, 2023. Posted in Dividend Reports And Estimates.

TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the estimated annual capital gains distributions for the Vanguard ETFs listed below for the 2023 tax year. This is an update to the estimated annual capital gains distributions announced on November 15, 2023. Please note that these are estimated amounts only, as of December 15, 2023, and could change if the Vanguard ETFs experience subscriptions or redemptions prior to the ex-dividend date. These estimates are for the year-end capital gains distributions only, which will be re-invested and the resulting units immediately consolidated, so that the number of units held by each investor will not change. These estimates do not include estimates of ongoing monthly or quarterly cash distribution amounts, which are reported in a separate press release. Vanguard...

PSB Holdings, Inc. announces semi-annual cash dividend of $0.30 per share

Written by Customer Service on December 20, 2023. Posted in Public Companies.

WAUSAU, Wis., Dec. 20, 2023 (GLOBE NEWSWIRE) — PSB Holdings, Inc. (OTCQX: PSBQ), parent company of Peoples State Bank, is pleased to announce that on December 19, 2023, its Board of Directors declared a regular semi-annual cash dividend of $0.30 per share of the Company’s common stock. The dividend is payable January 29, 2024 to shareholders of record as of January 10, 2024 and represents an increase of 20.0% over the $0.25 per share semi-annual cash dividend declared on December 20, 2022. The current dividend continues a 59-year tradition of cash dividends to PSB shareholders including 30 consecutive years of increased cash dividends declared per share. PSB President and CEO Scott M. Cattanach said, “We are proud of our long history of growing dividend payments to shareholders. Our franchise remains on sound footing enabling us...

Tidewater Presents Charity Outing Proceeds to Food Bank of Delaware

Written by Customer Service on December 20, 2023. Posted in Public Companies.

Tidewater Team Delivers Holiday Cheer and Presents Charity Outing Proceeds TIDEWATER TEAM DELIVERS HOLIDAY CHEER AND PRESENTS CHARITY OUTING PROCEEDS: (Pictured Left to Right) Joseph Cuccinello, Tidewater CPCN Coordinator and Event Organizer, Kirsten E. Higgins, Vice President, Tidewater Utilities; Larry Haas, Chief Development Officer – Food Bank of Delaware; Bruce E. Patrick, President, Tidewater Utilities; Chad Robinson Director of External Affairs, Food Bank of DE and Susan DeNardo, Community Development Manager, Food Bank of DE. DOVER, Del., Dec. 20, 2023 (GLOBE NEWSWIRE) — Tidewater Utilities, Inc. (Tidewater), a water service provider and a wholly-owned subsidiary of Middlesex Water Company recently presented a check for $35,000 to the Food Bank of Delaware at the Food Banks’s new Milford, DE location. The donation...

Alphavest Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders

Written by Customer Service on December 20, 2023. Posted in Public Companies.

New York, New York, Dec. 20, 2023 (GLOBE NEWSWIRE) — Alphavest Acquisition Corp (NASDAQ: ATMV) (the “Company”) announced today that the Company’s Extraordinary General Meeting of Shareholders (the “Extraordinary General Meeting”) was convened on December 20, 2023 at 12:00 p.m. Eastern Time and adjourned in order to solicit additional votes on the matters listed in the notice of extraordinary general meeting and the proxy statement. The Extraordinary General Meeting has been adjourned to December 21, 2023 at 1:30 p.m. Eastern Time and will continue to be held virtually. Only shareholders of record, as of the record date, December 7, 2023 (the “Record Date”), are entitled to vote at the Extraordinary General Meeting, either in person or by proxy. Proxies previously submitted in respect of the Extraordinary General Meeting will be...

CAPREIT Announces $101MM in New Strategic Transactions

Written by Customer Service on December 20, 2023. Posted in Public Companies.

TORONTO, Dec. 20, 2023 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX:CAR.UN) announced today that, since its last transaction press release on September 5, 2023, it has completed two strategically aligned acquisitions of newly constructed Canadian rental properties for an aggregate purchase price of $90.5 million. CAPREIT also announced that it has disposed of two non-core buildings in Canada for combined consideration of $10.3 million, in addition to closing on the previously announced $53.9 million strategic sale in Calgary, Alberta. All amounts disclosed herein exclude transaction costs. This month, CAPREIT acquired a newly constructed 12-storey, concrete purpose-built rental apartment containing 114 high-quality residential suites and over 5,000 square feet of commercial retail...

Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock

Written by Customer Service on December 20, 2023. Posted in Public Companies.

BRISBANE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (NASDAQ: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced the pricing of an underwritten public offering of 25,035,000 shares of its common stock and pre-funded warrants to purchase 18,379,861 shares of common stock. The shares of common stock are being sold at a price of $2.88 per share and the pre-funded warrants are being sold at a price of $2.879 per share. The total gross proceeds to Annexon are expected to be approximately $125.0 million, before deducting underwriting discounts and commissions and other offering expenses payable by Annexon. The offering is expected to close on December 26, 2023,...

Kering: Monthly statement on the total number of shares and voting rights (December 2023)

Written by Customer Service on December 20, 2023. Posted in Public Companies.

Kering – Statement Number of Shares and voting rights – 12.15.2023 KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS December 20, 2023 Monthly statementon the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers) Date Total number ofshares Total number of voting rights theoretical 1 exercisable 2 December 15, 2023 123,420,778 176,572,113 175,733,266 1 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223‑11 of AMF General Regulation). 2 Excluding treasury shares stripped of voting rights. Attachment Kering – Statement...

Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint

Written by Customer Service on December 20, 2023. Posted in Public Companies.

Alignment with FDA on Best Corrected Visual Acuity ≥ 15-Letter Loss as Primary Outcome Measure – Representing the Highest Value Outcome to Patients and Physicians ARCHER II, a Global Sham-Controlled Trial Supporting a Potentially Faster Path to Registration, Expected to Initiate in Mid-2024 ARROW, a Head-to-Head Trial using SYFOVRE® as an Injection Comparator to Differentiate Vision Protection from Slowing of Lesion Growth, Expected to Initiate in Late 2024 BRISBANE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammation-related diseases, today outlined its global registrational program for ANX007, a first-in-class C1q and classical complement inhibitor, for the treatment...

Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway

Written by Customer Service on December 20, 2023. Posted in Public Companies.

Target Levels of Active Drug Achieved in Healthy Volunteers with Oral Twice-Daily Dosing; Supportive Impact on Pharmacodynamic Biomarker of Complement Activity ANX1502 Generally Well Tolerated Across Cohorts with No Serious Adverse Events Tablet Formulation of ANX1502 Expected to Advance into Proof-of-Concept Study in Patients with Cold Agglutinin Disease (CAD) in 2024 BRISBANE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammation-related diseases, today reported results from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) healthy volunteer study of ANX1502, a first-in-kind oral, selective small molecule inhibitor that targets the active form...

CVB Financial Corp. Announces 137th Consecutive Quarterly Cash Dividend

Written by Customer Service on December 20, 2023. Posted in Dividend Reports And Estimates.

ONTARIO, CA, Dec. 20, 2023 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the fourth quarter of 2023. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on December 20, 2023. The quarterly dividend will be payable on or about January 22, 2024 to shareholders of record as of January 5, 2024. “We are pleased to announce our 137th consecutive quarterly cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate OverviewCVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with approximately $16 billion in total assets. Citizens Business...

Day: December 20, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice